The Case For US FDA To Be More Political In Its Approval Decisions

No one thinks it is a good idea for the US FDA Commissioner or some other higher up political actor to decide when and if to approve new drug applications. But it might not be so bad if the scientific staff at FDA paid a bit more attention to ‘political’ issues before making some decisions.

US FDA In the political blender (Nielsen Hobbs; the Pink Sheet | Alamy images)
FDA SHOULD BETTER ASSESS POLITICAL SPIN IF IT DOES NOT WANT TO SEE ITS DECISIONS CUT TO PIECES. • Source: Nielsen Hobbs; the Pink Sheet | Alamy images

More from US FDA

More from Agency Leadership